1The ACE inhibitors in diabetic nephropathy trialist group. Should all patients with type 1 diabetes mellitus and microalbuminuria receive angiotensin - converting enzyme inhibitors? A meta- analysis of individual patient data[J]. Ann Inter Med,2001,134(2) :370 -379.
3Bonnet F, Cooper ME, Kawachi H, et al. Irbesartan normalizes the deficiency in glomerular nephrin expression in a model of diabetes and hypertension [J]. Diabetologia,2001,44 :874 - 877.
4The ACE inhibitors in diabetic nephropthy trialist group.Should all patients with type 1 diabetes mellitus and microalbuminuria receive angiotensin-converting enzyme inhibitors? A meta-analysis of individual patient data[J]. Ann Intern Med,2001,134(2):370-379.
5Parving H H, Lehnert H, Brochner-Mortensen J, et al. The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes[J]. N Engl J Med, 2001,345(12):870-878.
6Lewis E J,Hunsicker L G,Clarke W R, et al .Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes[J].N Engl J Med,2001,345(12):851-860.
7Brenner B M,Cooper M E,Zeeuw D, et al. Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy[J]. N Engl J Med, 2001,345 (12):861-869.
8Heller J ,Dunlay M C,Sweet C S, et al. Comparative effects of the angiotensin Ⅱ receptor blocker EXP 3174 and of the angiotensin converting enzyme inhibitor captopril on renal glomerular hemodynamics in the dog[J]. Kidney Blood Press Res, 1997,20(5) :391-397.
9Morgensen C E, Neldam S, Tikkanen I, et al. Randomised controlled trial of dual blockade of renin-angiotensin system in patients with hypertension, microalbuminuria, and non-insulin dependent diabetes: the candesertan and lisinopril microalbuminuria(CLAM) study[J]. BMJ, 2000,321 (7274) :1440-1444.
10Azizi M,Chatellier G,Guyene T T, et al. Addictive effects of combined angiotensin-converting enzyme inhibition and angiotensin Ⅱ antagonism on blood pressure and renin release in sodium-depleted normotensiues [J ]. Circulation, 1995, 92(4) : 825-834.
3The ACE inhibitors in diabetic nephropathy trialist group. Should all patients with type 1 diabetes mellitus and microalbuminuria receive angiotensin- converting enzyrne inhibitors? A metaanalysis of in2 dividnal patient data [J]. Arm InterMed, 200l, 134 (2): 370 - 379.
4Bonnet F,Cooper ME,Kawaclli H, et al. Irbenormalizes the deficiency in glomendar nephrm expression in a model of diabetes and hypertension [ J ]. Diabetologia, 2001, 44: 874 - 877.
